BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine

Phase 1

Terminated

Conditions: Meningitis
Neoplasms

Interventions: Drug: Gemcitabine

First Posted Date: 2003-12-18

Last Posted Date: 2012-11-12

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 10

Registration Number: NCT00074607

Locations: 🇺🇸
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
National Cancer Institute, Bethesda, Maryland, United States

and more 2 locations

Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation

Not Applicable

Completed

Conditions: Kidney Cancer

First Posted Date: 2003-12-11

Last Posted Date: 2015-01-29

Lead Sponsor: Baylor College of Medicine

Registration Number: NCT00073879

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML

Phase 2

Terminated

Conditions: Chronic Myeloproliferative Disorders
Leukemia
Myelodysplastic Syndromes

Interventions: Radiation: Total Body Irradiation
Drug: Fludarabine
Drug: Campath 1H

First Posted Date: 2003-10-07

Last Posted Date: 2012-10-10

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 7

Registration Number: NCT00069992

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
The Methodist Hospital, Houston, Texas, United States

Study of Antioxidants and Oxidants in Malnourished Children

Not Applicable

Completed

Conditions: Kwashiorkor
Protein-energy Malnutrition
Marasmus

Interventions: Dietary Supplement: sulfur amino acids

First Posted Date: 2003-09-17

Last Posted Date: 2017-08-01

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 86

Registration Number: NCT00069134

Locations: 🇯🇲
Tropical Metabolism Research Unit, University of the West Indies, Kingston, Saint Andrew, Jamaica

Intrathecal Mafosfamide

Phase 1

Completed

Conditions: Malignant Meningeal Neoplasms

First Posted Date: 2003-06-18

Last Posted Date: 2020-03-04

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 65

Registration Number: NCT00062881

Locations: 🇺🇸
Children'sHospital Los Angeles, Los Angeles, California, United States
🇺🇸
Children's Hospital and Medical Center, Seattle, Washington, United States
🇺🇸
Pediatric Branch, National Cancer Institute, Bethesda, Maryland, United States

and more 6 locations

Study of Irinotecan on a Weekly Schedule in Children

Phase 1

Completed

Conditions: Cancer

Interventions: Drug: Irinotecan

First Posted Date: 2003-06-18

Last Posted Date: 2020-03-04

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 23

Registration Number: NCT00062842

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma

Phase 1

Completed

Conditions: Hodgkin Disease
Lymphoepithelioma
Leiomyosarcoma
Non Hodgkin Lymphoma

Interventions: Biological: LMP1/2 CTLs (ALCI - Group C)
Biological: LMP1/2 CTLs (ALCI - Group B)
Biological: LMP1/2 CTLs (ALCI - Expansion Group B)
Biological: LMP1/2 CTLs (ALCI - Expansion Group C)
Biological: LMP1/2 CTLs (ALCI - Expansion - Group A)
Biological: LMP1/2 CTLs (ALCI - Group A)
Biological: LMP2 CTLs (ALSCER - Group A)
Biological: LMP2 CTLs (ALSCER - Group C)
Biological: LMP2 CTLs (ALSCER - Group B)

First Posted Date: 2003-06-18

Last Posted Date: 2020-06-09

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 74

Registration Number: NCT00062868

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
The Methodist Hospital, Houston, Texas, United States

Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma

Phase 1

Completed

Conditions: Neuroblastoma

Interventions: Procedure: Skin Biopsy
Genetic: Gene Modified Neuroblastoma Cells

First Posted Date: 2003-06-18

Last Posted Date: 2012-10-29

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 9

Registration Number: NCT00062855

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Valacyclovir in Immunocompromised Children

Phase 1

Completed

Conditions: Shingles
Bone Marrow Transplantation

Interventions: Drug: Valacyclovir

First Posted Date: 2003-04-30

Last Posted Date: 2020-03-04

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 37

Registration Number: NCT00059592

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells

Phase 1

Completed

Conditions: Chronic Lymphocytic B-Leukemia

First Posted Date: 2003-04-15

Last Posted Date: 2012-05-23

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 9

Registration Number: NCT00058786

Locations: 🇺🇸
The Methodist Hospital, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy